EW

Emmanuel Walter

Scientific Advisor at Vaxcyte

Dr. Emmanuel Walter is a Professor of Pediatrics at Duke University School of Medicine, the Chief Medical Officer of the Duke Human Vaccine Institute (DHVI) and the Director of the Duke Vaccine and Trials Unit. Dr. Walter provides strategic and operational leadership for clinical research conducted at the DHVI. In addition, he provides oversight of regulatory compliance for DHVI clinical research activities. Dr. Walter has dedicated his career to advancing research and clinical practice in vaccinology, infectious diseases and child health. He currently serves as the principal investigator for the Duke Clinical Core of the Collaborative Influenza Vaccine Innovations Centers funded by the National Institute of Allergy and Infectious Diseases (NIAID). Dr. Walter is the Duke Co-Principal Investigator for the NIAID Vaccine and Treatment Evaluation Unit, which conducts clinical trials of vaccines and treatments for infectious diseases. He is also the Duke Principal Investigator for the Centers for Disease Control and Prevention-funded Clinical Immunization Safety Assessment Project, which conducts studies to identify risk factors and preventive strategies for adverse events following immunization, particularly in special populations. Dr. Walter received his MPH from the University of North Carolina – Chapel Hill, MD from the University of Maryland, Baltimore and BS from the University of Notre Dame.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Vaxcyte

2 followers

Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.


Industries

Employees

11-50

Links